These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24252536)

  • 1. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats.
    Kitic M; Hochmeister S; Wimmer I; Bauer J; Misu T; Mader S; Reindl M; Fujihara K; Lassmann H; Bradl M
    Acta Neuropathol Commun; 2013 May; 1():5. PubMed ID: 24252536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-activation in neuromyelitis optica lesions plays a role in their formation.
    Pohl M; Kawakami N; Kitic M; Bauer J; Martins R; Fischer MT; Machado-Santos J; Mader S; Ellwart JW; Misu T; Fujihara K; Wekerle H; Reindl M; Lassmann H; Bradl M
    Acta Neuropathol Commun; 2013 Dec; 1():85. PubMed ID: 24367907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.
    Zeka B; Hastermann M; Hochmeister S; Kögl N; Kaufmann N; Schanda K; Mader S; Misu T; Rommer P; Fujihara K; Illes Z; Leutmezer F; Sato DK; Nakashima I; Reindl M; Lassmann H; Bradl M
    Acta Neuropathol; 2015 Dec; 130(6):783-98. PubMed ID: 26530185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
    Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
    Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
    Zhang H; Bennett JL; Verkman AS
    Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
    Oji S; Nicolussi EM; Kaufmann N; Zeka B; Schanda K; Fujihara K; Illes Z; Dahle C; Reindl M; Lassmann H; Bradl M
    PLoS One; 2016; 11(3):e0151244. PubMed ID: 26990978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
    Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
    Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.
    Vincent T; Saikali P; Cayrol R; Roth AD; Bar-Or A; Prat A; Antel JP
    J Immunol; 2008 Oct; 181(8):5730-7. PubMed ID: 18832732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
    Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
    Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.
    Ratelade J; Verkman AS
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1519-30. PubMed ID: 22713791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.
    Guo Y; Weigand SD; Popescu BF; Lennon VA; Parisi JE; Pittock SJ; Parks NE; Clardy SL; Howe CL; Lucchinetti CF
    Acta Neuropathol; 2017 Apr; 133(4):597-612. PubMed ID: 28184993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
    Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
    Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica pathogenesis and aquaporin 4.
    Graber DJ; Levy M; Kerr D; Wade WF
    J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica.
    Duan T; Smith AJ; Verkman AS
    J Neuroinflammation; 2018 Oct; 15(1):294. PubMed ID: 30348195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.
    Zeka B; Hastermann M; Kaufmann N; Schanda K; Pende M; Misu T; Rommer P; Fujihara K; Nakashima I; Dahle C; Leutmezer F; Reindl M; Lassmann H; Bradl M
    Acta Neuropathol Commun; 2016 Aug; 4(1):82. PubMed ID: 27503347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.